The plasminogen activator inhibitor type 1 ( PAI-1 ) is a primary factor in fibrinolysis system . This kind of therapeutic medicine using PAI-1 as the target , which is among the hotspots of thrombolytic researching .
纤溶酶原激活剂抑制物-1(PAI-1)是纤溶系统的重要因子,以其作为靶点研发的溶栓药物在国内外一直是抗血栓新药物研究的热点。